Favennec D F
Service Ophtalmologie CHU Pontchailloux Rennes.
Allerg Immunol (Paris). 1989 Jun;21(6):243-6.
A 4 week open study was carried out to evaluate the efficacy and safety of astemizole in the treatment of allergic conjunctivitis 31 patients were included in the study. Global efficacy, with 10 mg astemizole OD, was rated good or excellent in 100% of treated patients. A marked improvement of the main symptoms was noted at day 15. No side effects whether of the anticholinergic type or of the drowsiness type, were observed during the whole study. Astemizole appears to be a particularly interesting symptomatic treatment of allergic conjunctivitis.
开展了一项为期4周的开放性研究，以评估阿司咪唑治疗过敏性结膜炎的疗效和安全性。31名患者纳入该研究。使用10毫克阿司咪唑每日一次治疗，所有患者的总体疗效评定为良好或优秀。在第15天时主要症状有显著改善。在整个研究过程中未观察到抗胆碱能类或嗜睡类的副作用。阿司咪唑似乎是一种治疗过敏性结膜炎特别有效的对症药物。
